Search Results - "Kirkegaard, Jannie"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    PB2682: ANTI‐NEOPLASTIC TREATMENT, BASED ON PRO DATA REPORTED THROUGH A MHEALTH APP SOLUTION IN MULTIPLE MYELOMA PATIENTS

    PB2682: ANTI‐NEOPLASTIC TREATMENT, BASED ON PRO DATA REPORTED THROUGH A MHEALTH APP SOLUTION IN MULTIPLE MYELOMA PATIENTS by Kirkegaard, Jannie

    Published in HemaSphere (08-08-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Self-Administration Of Subcutaneous Bortezomib At Home In Cancer Patients With Multiple Myeloma. Patients And Health Professionals Perspectives And Organizational Aspects, In A Mixed Methods Study

    Self-Administration Of Subcutaneous Bortezomib At Home In Cancer Patients With Multiple Myeloma. Patients And Health Professionals Perspectives And Organizational Aspects, In A Mixed Methods Study by Kirkegaard, Jannie

    Published in International journal of integrated care (04-11-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    P-132 Daratumumab Treatment in the Patients’ Own Home

    P-132 Daratumumab Treatment in the Patients’ Own Home by Lund, Thomas, Kirkegaard, Jannie, Gundesen, Michael Tveden, Dieperink, Karin Brochstedt, Rosenberg, Tine

    Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method study

    Home is best. Self-administration of subcutaneous Bortezomib at home in patients with multiple myeloma - A mixed method study by Kirkegaard, Jannie, Lundholm, Birgitte Wolf, Rosenberg, Tine, Lund, Thomas, Gundesen, Michael Tveden, Dieperink, Karin Brochstedt

    “…To examine the perspectives of patients and healthcare professionals of self-administration of subcutaneous (SC) injection of Bortezomib in the homes of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases – A mixed method study

    Making decisions for follow-up chemotherapy based on digital patient reported outcomes data in patients with multiple myeloma and other M protein diseases – A mixed method study by Rosenberg, Tine, Kirkegaard, Jannie, Tveden, Michael Gundesen, Hyldig, Nana, Dieperink, Karin Brochstedt, Steffensen, Nanna Hanneberg, Ulriksen, Stine Brøgger, Lund, Thomas

    “…To test if Patient Reported Outcomes (PRO) data can replace physical on-site consultation in determining if patients with multiple myeloma, AL amyloidosis, or…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: